30152-57-9

Basic information

• Product Name: Spiro[3.3]heptan-2-one
• Synonyms: Spiro[3.3]heptan-2-one;Spiro[3.3]heptan-2-one - S10809
• CAS NO: 30152-57-9
• Molecular Formula: C₇H₁₀O
• Molecular Weight: 110.1537
• Mol File: 30152-57-9.mol

Chemical Properties

• Boiling Point: 175.3±8.0 °C(Predicted)
• Appearance: /
• Density: 1.05±0.1 g/cm3(Predicted)
• CAS DataBase Reference: Spiro[3.3]heptan-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: Spiro[3.3]heptan-2-one(30152-57-9)
• EPA Substance Registry System: Spiro[3.3]heptan-2-one(30152-57-9)

Safety Data

• Hazardous Substances Data: 30152-57-9(Hazardous Substances Data)

Usage

Uses

Used in Food Industry:
Spiro[3.3]heptan-2-one is used as a flavoring agent for its pleasant odor, enhancing the taste and aroma of various food products.
Used in Cosmetic Industry:
Spiro[3.3]heptan-2-one is used as a fragrance ingredient in cosmetic products, providing a pleasant scent and improving the overall sensory experience.
Used in Perfumery:
Spiro[3.3]heptan-2-one is used as a component in perfumes and fragrances, contributing to the creation of unique and appealing scents.
Used as a Chemical Intermediate:
Spiro[3.3]heptan-2-one serves as a valuable chemical intermediate in organic synthesis, enabling the production of various chemical compounds and materials.
Used in Antimicrobial Applications:
Spiro[3.3]heptan-2-one has been investigated for its antimicrobial properties, making it a potential candidate for use in sanitizing products and controlling microbial growth.
Used in Insecticidal Applications:
Due to its insecticidal properties, Spiro[3.3]heptan-2-one can be utilized in pest control and management, providing an effective solution against insect infestations.

Upstream product

• 87611-63-0 5,5-dichlorospiro<3.3>heptan-6-one 
• 1120-56-5 methylidenecyclobutane 

Downstream Products

• 1255099-41-2 spiro[3.3]heptane-2-amine 

Relevant articles and documents

N-(PYRIDIN-2-YLSULFONYL)CYCLOPROPANECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF A CFTR MEDIATED DISEASE

The invention relates to heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.

5, 7-SUBSTITUTED-IMIDAZO [1, 2-C] PYRIMIDINES AS INHIBITORS OF JAK KINASES

Compounds of Formula I: (Formula should be inserted here) and stereoisomers and pharmaceutically acceptable salts and solvates thereof in which R1, R2, R3, R4, R5, R6, R7, X1 and X2 have the meanings given in the specification, are inhibitors of one or more JAK kinases and are useful in the treatment of autoimmune diseases, inflammatory diseases, rejection of transplanted organs, tissues and cells, as well as hematologic disorders and malignancies and their co-morbidities.

Pyrrolidine and thiazolidine compounds

Compounds of formula (I): wherein: X1 represents an atom or group selected from CR4aR4b, O, S(O)q1 and NR5, wherein R4a, R4b, q1 and R5 are as defined in the description, m1 represents zero or an integer from 1 to 4 inclusive, m2 represents an integer from 1 to 4 inclusive, n1 and n2, which may be identical or different, each represent an integer from 1 to 3 inclusive, R1 represents hydrogen or a group selected from carboxy, alkoxycarbonyl, optionally substituted carbamoyl and optionally substituted alkyl, R2 represents hydrogen or alkyl, Ak represents an optionally substituted alkylene chain, p represents zero, 1 or 2, R3 represents hydrogen or cyano, X2 and X3, which may be identical or different, each represent either S(O)q2, or CR6aR6b, wherein q2, R6a and R6b are as defined in the description, its optical isomers, where they exist, and its addition salts with a pharmaceutically acceptable acid. Medicinal products containing the same which are useful as DPP-IV inhibitors.